USFDA concludes inspection at Alkem Laboratories’ Bioequivalence Center at Taloja

30 Jul 2021 Evaluate

The United States Food and Drug Administration (USFDA) had conducted a remote and virtual Bio-Analytical inspection of Alkem Laboratories’ Bioequivalence Center located at Taloja, Maharashtra from July 26, 2021 to July 28, 2021. At the end of the inspection, no Form 483 was issued.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5310.00 65.20 (1.24%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.